| |
|
|
|
Tonix Pharm Hld  
|
|
0.6076 0.036 (0.06%) |
11-30 15:23 |
|
Open: |
0.58 |
Pre close: |
0.572 |
Target:
|
0.79 
|
|
High: |
0.63 |
Low: |
0.561 |
Resistance:
|
0.68
0.79
|
|
Volume: |
13,933,017 |
Market Cap: |
95M |
Support:
|
0.57
0.51
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.57
|
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
0.57 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
0.84  |
Stochastic Oscillator |
%K(14,3):
|
41.46 |
|
MA(250): |
0.86 |
%D(3): |
34.65 |
|
Average Volume(K) |
3-Month: |
565738
|
52-Week |
High:
|
2.46 |
|
10-Days: |
602616 |
Low: |
0.39 |
|
RSI |
RSI(14):
|
50.02 |
Change(%): |
-46.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.850 |
Return on Equity (ttm) |
-116.4 |
Shares Out. (M) |
156.58 |
|
EPS Est. Current Year |
-3.020 |
Return on Assets (ttm) |
-66.1 |
Shares Float (M) |
156.41 |
|
EPS Est. Next Year |
-2.470 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.05 |
|
EPS Est. Next Quarter |
-0.740 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
4.42 |
|
Forward EPS |
-19.330 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
781 |
|
Book Value (p.s.) |
0.450 |
EBITDA (p.s.) |
-0.270 |
P/E |
-0.72 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.35 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-41.37 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-33.12 |
P/CF |
-2.30 |
|
|
|
|
|
|
